The increasing prevalence of human papillomavirus (HPV)-related cancers, particularly cervical cancer, remains a pressing public health issue across Asia and the Pacific. According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women globally, with a disproportionate burden in low- and middle-income countries (LMICs), many of which are located in the Asia-Pacific region. Despite the availability of safe and effective vaccines, uptake remains uneven due to systemic, cultural, logistical, and political barriers.
In this context, the Asian Pacific Journal of Cancer Prevention (APJCP) and the Asian Pacific Organization for Cancer Prevention (APOCP) have jointly taken the initiative to host a hybrid symposium titled “HPV Vaccination in the Asian and Pacific Region: Achievements and Barriers” on June 20, 2025. Read more…